Dr. Patricia Farrell on Medika Life

The Medical Device That May Lead to Harm in People of Color

Testing medical equipment is aimed at ensuring that it applies to every patient, regardless of their race, but one piece missed the mark.

Several biological indicators used to assess our physical health have come into question; BMIBPtemperature, and oxygen readings. All of them may need revamping or a rethinking of ranges rather than rigid numbers, but we question one because of the device used to measure it.

Racial bias prevents many people from attending adequate schools, entering promising careers, and accessing adequate healthcare. This bias also affects where they can find suitable housing, and that housing may contribute to health difficulties brought on by pollution or vermin infestation. The situation, undeniably, is untenable, and anyone who believes in human rights will find each of these impediments anathema.

All the above is clear, but taking the situation two steps further will reveal the hidden extent of the potential damage raining down on anyone who is a victim of this bias. And, most disturbing, this further damage to health happens in the medical realm.

Socioeconomic factors lead to health risks such as asthma, and the need for ongoing, accurate treatment for asthma is mostly with inhalers. The condition is so severe that frequent emergency treatment is sought. Compared with white people with asthma, African American people with asthma are five times more likely to visit the emergency room for symptoms.

One of the inhalers of choice for asthma is albuterol, and here, again, there is a problem with treatment. A study of over 1,400 children revealed a genetic lack of appropriate response to this drug in some patients. And problems in sampling were apparent. We and others have documented the implications and challenges posed by the lack of non-European study populations in biomedical researchSampling bias is at the heart of one major problem in device engineering.

Once asthma treatment is sought, there still needs to be a resolution to the underlying measurement problem. While in the ER, how is the oxygen level of these patients determined? The usual initial route is to get a quick level using an oximeter slipped on a finger. It’s a rapid and supposedly accurate measure of how much oxygen the patient has in their blood; vital information.

Who questions the oximeter readings? The assumption is that the task is accurate because the device is FDA approved, made by a reputable company, and has been used for years in hospitals. But that conclusion is patently false.

The validity of the readings was made primarily on persons of European descent. How accurate would they be on anyone who did not meet that criterion? The answer would seem obvious.

Studies dating back to 2005 show pulse oximeters tend to overestimate the amount of oxygen a patient with darker skin may actually have in their blood. It’s simple physics: Melanin in skin absorbs some of the light the devices analyze to make their readings. The darker the skin, the more melanin there is, and the less light passes through.

If the readings are wrong, how does that have an impact on treatment? Again, no question that there is a bias in oxygen levels leading to changes in medical care.

The FDA issued an alert on oximeters, but did everyone dispose of their older, inaccurate devices in healthcare and the home? Other factors affect these readings, including poor circulation, skin pigmentation, skin thickness, skin temperature, current tobacco use, and use of fingernail polish.

NASA had developed guidelines and devices for more accurately measuring blood oxygen, but the corporation involved in it changed its marketing direction and the device was dropped.

We know that the disturbing use of oximeters tested in Japan (with a relatively homogenous population) may lead to delays in treatment in persons with darker skin. How is this permissible? It’s not, and the NASA devices should be considered again.

Follow this author on Substack

PATIENT ADVISORY

Medika Life has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by Medika Life

Pat Farrell PhD
Pat Farrell PhDhttps://medium.com/@drpatfarrell
I'm a licensed psychologist in NJ/FL and have been in the field for over 30 years serving in most areas of mental health, psychiatry research, consulting, teaching (post-grad), private practice, consultant to WebMD and writing self-help books. Currently, I am concentrating on writing articles and books.

DR PATRICIA FARRELL

Medika Editor: Mental Health

I'm a licensed psychologist in NJ/FL and have been in the field for over 30 years serving in most areas of mental health, psychiatry research, consulting, teaching (post-grad), private practice, consultant to WebMD and writing self-help books. Currently, I am concentrating on writing articles and books.

Patricia also acts in an editorial capacity for Medika's mental health articles, providing invaluable input on a wide range of mental health issues.

Buy this author on Amazon

Connect with Patricia

Website

Facebook

Twitter

Youtube

All articles, information and publications featured by the author on thees pages remain the property of the author. Creative Commons does not apply and should you wish to syndicate, copy or reproduce, in part or in full, any of the content from this author, please contact Medika directly.